Low Risk of Renal Dysfuntion in Patients With Wilms Tumor Undergoing Partial Nephrectomy
the ONA take:
Patients with unilateral Wilms tumor who underwent unilateral radical nephrectomy without nephrotoxic chemotherapy or ionizing radiotherapy appear to have a low risk for developing significant long-term renal dysfunction, according to a study published last month in the journal Cancer.
Wilms tumor is a malignant tumor of the kidney and is the most common type of kidney cancer in children. The American Cancer Society estimates that there are about 500 new cases of Wilms tumor diagnosed in the United States each year.
For the study, researchers sought to evaluate the impact of partial nephrectomy on long-term renal dysfunction in children with unilateral Wilms tumor who were not treated with nephrotoxic chemotherapy or ionizing radiation.
Results showed that during the 19.6 years of median follow-up, 21.3% of the 75 patients had an estimated glomerular filtration rate (eGFR) <90 mL/minute/1.73m2 and 12.5% had proteinuria. Researchers found that no patients had an eGFR <60 mL/minute/1.73m2 and 6.7% of patients had hypertension.
Patients with unilateral Wilms tumor who underwent unilateral radical nephrectomy appear to have low risk for renal dysfunction.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|